Net Profit Margin ratio Analysis of Merrimack Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY NPM
Period Ending - Dec-23
Poor NPM
0
Period Ending - Dec-22
Excellent NPM
346.97
Growth
0 %
Trailing Twelve Months NPM
Period Ending - Dec-23
Poor NPM
0
Most recent Quarter NPM
Period Ending - Mar-24
Poor NPM
0
NPM Analysis of Merrimack Pharmaceuticals Inc
| NPM Ratio of Merrimack Pharmaceuticals Inc with value of 0 indicates that a company is not able to control its costs efficiently and provides goods or services at a price that is insufficient to recover its costs in trailing twelve months. |
| NPM Ratio of Merrimack Pharmaceuticals Inc with value of 0 indicates that a company is not able to control its costs efficiently and provides goods or services at a price that is insufficient to recover its costs inlatest Quarter ending on Mar-24. |
| NPM Ratio of MACK has fallen by 0 % Compared to previous Financial Year. |
| NPM Ratio with value of 346.97 was highest in Year Dec-22 in last Five Years. |
| NPM Ratio with value of 0 was lowest in Year Dec-23 in last Five Years. |
| Latest NPM Ratio with value of 0 is lower than Average NPM of 69.39 in last five years. |
Other NPM Related Info of MACK that may interest you.
Merrimack Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| MACK | 15.13 | 15.13 | 0 % | Biotechnology |
Defination of Net Profit Margin
Net Margin is the company's Net Profit divided by the Total Revenue. This profitability metric indicates how much a net profit is generated for each rupee of revenue earned. In simple terms, it tells how much the company is generating profit for each rupee of revenue earned in percentage. It measures the company's profitability and management's capability to manage its expenses to generate profit. more ..
NPM Related Ratios
| ReturnOnEquity | EBITDAMargin |
Tsr Profitability Index
| No Significant Profitability | |
FY - Historical Net Profit Margin of Merrimack Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| NPM | 0 | 346.97 | 0 | 0 | 0 | 0 | 0 |
| Change | 0 % | 0 % |
FY Chart of Net Profit Margin of Merrimack Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)